The contract is part of the grant DIN2021-011811
Torres Quevedo 2023 grant to hire a PhD in Chemistry for the project “Design and Synthesis of Peptide-Shuttle-Antibody-Drug Conjugates for CNS Tumors.”
File Number: PTQ2022-012493.
Title: Gate2Brain’s Business Plan
Project within the Neotec program framework
Gate2Brain SL has been the beneficiary of a project subsidized by the CDTI with the collaboration of the Ministry of Science and Innovation and co-financed by the European Union – Next Generation EU.
File Number SNEO-20211130.
Title: Spain and India, two countries working in the clinical development for a novel therapy against pediatric brain tumors
Project within Multipaís 2024 program framework
Gate2Brain SL has been the beneficiary of a project subsidized by the CDTI with the collaboration of the Ministry of Science and Innovation and co-financed by the European Union – Next Generation EU.
File number 00171146 / PAIS-20241020
Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.
Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com
